MedPath
NMPA Product

Drospirenone and Ethinylestradiol tablets

Product approved by National Medical Products Administration (CN)

Basic Information

Drospirenone and Ethinylestradiol tablets

屈螺酮炔雌醇片

每片含炔雌醇0.03mg和屈螺酮3mg

片剂

Regulatory Information

国药准字H20249620

Approved

化学药品

December 1, 2024

Company Information

Active Ingredients

Drospirenone and Ethinylestradiol Tablets

© Copyright 2025. All Rights Reserved by MedPath